A

Ardelyx

ARDX

5.52500
USD
-0.025
(-0.45%)
Market Open
Volume
84,141
EPS
0
Div Yield
0
P/E
-21
Market Cap
1,353,712,052
Related Instruments
A
AGEN
-0.05000
(-0.83%)
5.99000 USD
A
ALNY
31.19
(13.13%)
268.66 USD
A
AMRX
-0.16500
(-2.25%)
7.17000 USD
A
APTX
0
(0%)
0.000000 USD
G
GLPG
0.270
(1.01%)
26.970 USD
K
KZR
-0.01650
(-2.54%)
0.63350 USD
News

Title: Ardelyx

Sector: Healthcare
Industry: Biotechnology
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.